|
121 |
Can systematic reviews contribute to regulatory decisions? Enthalten in European journal of clinical pharmacology 7.1.2017: 1-3
|
|
|
122 |
News from the 45th ESCP Symposium on Clinical Pharmacy, 4–6 October 2016, Oslo Enthalten in Drugs & therapy perspectives 7.1.2017: 1-5
|
|
|
123 |
Who is a ‘healthy subject’?—consensus results on pivotal eligibility criteria for clinical trials Enthalten in European journal of clinical pharmacology 7.1.2017: 1-8
|
|
|
124 |
Assessment of effects of atomoxetine in adult patients with ADHD: consistency among three geographic regions in a response maintenance study Enthalten in ADHD Attention Deficit and Hyperactivity Disorders 6.1.2017: 1-8
|
|
|
125 |
Quality of life with rivaroxaban in patients with non-valvular atrial fibrilation by therapeutic compliance Enthalten in Quality of life research 6.1.2017: 1-8
|
|
|
126 |
Latent Inhibition Reduces Nocebo Nausea, Even Without Deception Enthalten in Annals of behavioral medicine 4.1.2017: 1-10
|
|
|
127 |
Common data elements for secondary use of electronic health record data for clinical trial execution and serious adverse event reporting Bruland, Philipp. - Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2016
|
|
|
128 |
Effect of Statins on Venous Thromboembolic Events: A Meta-analysis of Published and Unpublished Evidence from Randomised Controlled Trials Rahimi, Kazem. - Würzburg : Universität Würzburg, 2016
|
|
|
129 |
Individualized versus standardized risk assessment in patients at high risk for adverse drug reactions (IDrug) – study protocol for a pragmatic randomized controlled trial Stingl, Julia. - Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2016
|
|
|
130 |
Measuring spatial accessibility of health care providers – introduction of a variable distance decay function within the floating catchment area (FCA) method Bauer, Jan. - Frankfurt am Main : Universitätsbibliothek Johann Christian Senckenberg, 2016
|
|